Endothelin-1 induces lysyl oxidase expression in pulmonary artery smooth muscle cells.


Journal

Canadian journal of physiology and pharmacology
ISSN: 1205-7541
Titre abrégé: Can J Physiol Pharmacol
Pays: Canada
ID NLM: 0372712

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 3 7 2020
medline: 6 7 2021
entrez: 3 7 2020
Statut: ppublish

Résumé

The increase in thickening of the arterial wall of pulmonary arterial hypertension (PAH) includes cellular proliferation as well as matrix deposition and interrupted internal elastic lamina (IEL) consisting of a thick homogeneous sheet of elastin. Little is, although, known about the detail of IEL formation in PAH. Endothelin-1 is overexpressed in pulmonary arterioles of PAH. We aimed to examine the expression of genes contributing to IEL formation in pulmonary artery smooth muscle cells (PASMCs) especially focused on lysyl oxidase (LOx), an exreacellular matrix enzyme that catalyzes the cross-linking of collagens or elastin. We quantified mRNA expressions of genes contributing to IEL formation including LOx in PASMCs using real-time quantitative polymerase chain reaction. We stimulated human PASMCs with endothelin-1 with prostacyclin or trapidil. Endothelin-1 significantly increased LOx expression. Prostacyclin and trapidil restored endothelin-1-induced LOx expression to the basal level. Endothelin-1 increased LOx expression strongly in PASMCs from PAH patients compared to those from controls. Trapidil reduced LOx expression only in PASMCs from PAH patients. Overexpressed endothelin-1 in PAH patients can increase expression of LOx and agitate cross-linking of elastin and collagen, resulting in ectopic deposition of these in the vascular media.

Identifiants

pubmed: 32615041
doi: 10.1139/cjpp-2019-0658
doi:

Substances chimiques

Endothelin-1 0
Collagen 9007-34-5
Elastin 9007-58-3
Epoprostenol DCR9Z582X0
LOX protein, human EC 1.4.3.13
Protein-Lysine 6-Oxidase EC 1.4.3.13
Trapidil EYG5Y6355E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-636

Auteurs

Hidekazu Maruyama (H)

Department of Cardiology, National Hospital Organization Kasumigaura Medical Center, Tsuchiura, Japan.
Faculty of Health Science, Tsukuba University of Technology, Tsukuba, Japan.
Division of Cardiovascular Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Laboratory of Physiology and Pharmacology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.

Satoshi Sakai (S)

Faculty of Health Science, Tsukuba University of Technology, Tsukuba, Japan.
Division of Cardiovascular Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Laurence Dewachter (L)

Laboratory of Physiology and Pharmacology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.

Céline Dewachter (C)

Laboratory of Physiology and Pharmacology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
Department of Cardiology, Erasme Academic Hospital, Brussels, Belgium.

Benoit Rondelet (B)

Department of Cardiac, Vascular and Thoracic Surgery, CHU UCL Namur, Yvoir, Belgium.

Robert Naeije (R)

Laboratory of Physiology and Pharmacology, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.

Masaki Ieda (M)

Division of Cardiovascular Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH